Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MorgenFund was an independent, customer-oriented fund and ETF investment platform based in Frankfurt am Main, Germany. It offered flexible custody solutions and access to a broad universe of funds for private, business, and institutional investors. The company operated as the largest fund platform in Germany with over €100 billion in assets under administration at its peak. As of November 30, 2022, MorgenFund GmbH was closed; DWS Group received a 30% stake as part of the closure process.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MorgenFund.